GlassScriptPhysician profile
Kristy Solis
NPI 1215584552
$23,226.11
in general payments reported to CMS, 2019-2025
59 companies · $2,930 in 2025
The $2,930 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $6,362 · 2022: $5,268 · 2023: $4,806 · 2024: $3,861 · 2025: $2,930.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $1,385 · Education: $42.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,168.76 |
| Travel and Lodging | $1,384.94 |
| Education | $42.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $2,173.56 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $2,060.09 | 2022-2025 | Leqvio |
| Amgen INC. | $1,537.23 | 2021-2025 | Evenity, Tepezza, Prolia |
| Astrazeneca Pharmaceuticals LP | $1,347.66 | 2021-2024 | Lokelma |
| Lilly USA, LLC | $1,258.25 | 2021-2025 | Mounjaro, Jardiance, Zepbound |
| Biohaven Pharmaceuticals, INC. | $1,148.06 | 2021 | |
| Abbvie INC. | $1,096.42 | 2021-2025 | |
| Mannkind Corporation | $1,025.49 | 2021-2025 | Afrezza |
| Radius Health, INC. | $990.35 | 2021-2025 | Tymlos |
| Xeris Pharmaceuticals, INC. | $886.63 | 2021-2025 | Gvoke Hypopen, Recorlev |
| Bayer Healthcare Pharmaceuticals INC. | $778.27 | 2021-2025 | |
| Dexcom, INC. | $733.81 | 2021-2024 | Dexcom G6 Transmitter |
| Boehringer Ingelheim Pharmaceuticals, INC. | $700.67 | 2021-2025 | Jardiance |
| Alexion Pharmaceuticals, INC. | $678.69 | 2021-2025 | Strensiq |
| Antares Pharma, INC. | $669.27 | 2021-2025 | Xyosted, Tlando, Nocdurna |
Show all 59 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Recordati_rare_diseases_inc. | $666.34 | 2021-2025 | Isturisa, Signifor Lar |
| Sanofi-Aventis U.S. LLC | $499.72 | 2021-2025 | |
| Corcept Therapeutics | $369.24 | 2021-2025 | Korlym |
| Horizon Therapeutics Plc | $361.59 | 2021-2023 | Tepezza |
| Ibsa Pharma INC. | $301.45 | 2021-2024 | Tirosint, Licart, Licart |
| Medtronic, INC. | $286.64 | 2021-2024 | Minimed 780g |
| Esperion Therapeutics, INC. | $274.18 | 2021-2025 | Nexletol |
| Beta Bionics, INC. | $252.36 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Ultragenyx Pharmaceutical INC. | $229.92 | 2021 | |
| Almatica Pharma LLC | $215.74 | 2024-2025 | Teriparatide |
| Astellas Pharma US INC | $201.84 | 2023-2025 | Veozah |
| Kyowa Kirin, INC. | $198.68 | 2023-2025 | Crysvita |
| Ascendis Pharma Endocrinology INC | $162.60 | 2024-2025 | Yorvipath |
| Lifescan, INC. | $155.58 | 2021-2022 | |
| Neurocrine Biosciences, INC. | $149.35 | 2024-2025 | |
| Eusa Pharma (US) LLC | $140.91 | 2022 | |
| Chiesi USA, INC. | $128.67 | 2024-2025 | Mycapssa |
| Tandem Diabetes Care, INC. | $127.40 | 2022-2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Insulet Corporation | $122.58 | 2023 | Omnipod |
| Argenx US, INC. | $120.06 | 2024 | Vyvgart Hytrulo |
| Amphastar Pharmaceuticals, INC. | $115.56 | 2024-2025 | |
| Averitas Pharma INC. | $96.15 | 2023-2024 | Qutenza |
| Ascensia Diabetes Care US INC. | $90.25 | 2022-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $82.88 | 2022 | |
| Pfizer INC. | $78.70 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $70.92 | 2021 | |
| Nestle Healthcare Nutrition INC. | $62.04 | 2021 | |
| Daiichi Sankyo INC. | $56.76 | 2024-2025 | Injectafer |
| Halozyme INC | $54.85 | 2023 | |
| Amarin Pharma, INC. | $54.05 | 2021-2022 | |
| Rhythm Pharmaceuticals, INC. | $52.54 | 2024 | Imcivree |
| Embecta Corp. | $46.21 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Amryt Pharma Holdings LTD | $45.17 | 2022 | |
| Madrigal Pharmaceuticals | $42.68 | 2025 | Rezdiffra |
| Ionis Pharmaceuticals, INC. | $30.68 | 2025 | Tryngolza |
| Acerus Pharmaceuticals Corporation | $30.49 | 2021 | |
| Tolmar, INC. | $30.01 | 2024 | |
| Soleno Therapeutics, INC. | $28.46 | 2025 | Vykat Xr |
| Bigfoot Biomedical INC | $23.36 | 2022 | |
| Acella Pharmaceuticals, LLC | $20.49 | 2023 | NP Thyroid 60 |
| Nevro Corp. | $18.68 | 2023 | Senza |
| Verity Pharmaceuticals INC. | $18.32 | 2025 | Tlando |
| Amneal Pharmaceuticals LLC | $15.01 | 2021 | |
| Grt US Holding, INC. | $12.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristy Solis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.